Showing results (341-350 of 365) with videos related to
Sort By:
Pageof 37
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2024
Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium SocietyHenry S Park, Andreas Rimner, Arya Amini, et al.International Journal of Radiation Oncology, Biology, Physics|September 27, 2021
American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung CancerArya Amini, Vivek Verma, Charles B Simone, et al.HIV Medicine|May 18, 2016
The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapyE J Edelman, K S Gordon, J P Tate, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839Martin J Edelman, Chen Hu, Quynh-Thu Le, et al.International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung CancerMelissa A L Vyfhuis, Whitney M Burrows, Neha Bhooshan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2017
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)Martin J Edelman, Xiaofei Wang, Lydia Hodgson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 studyGlenwood D Goss, Chris O'Callaghan, Ian Lorimer, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 23, 2024
American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic RadiotherapyArya Amini, Vlad G Zaha, Eman Hamad, et al.International Journal of Radiation Oncology, Biology, Physics|April 4, 2025
American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive SummaryCharles B Simone, Arya Amini, Indrin J Chetty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301Antonius A Miller, Daryl J Murry, Kouros Owzar, et al.Pageof 37